Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alternatives To Brief Summary Outlined In Draft Guidance

This article was originally published in The Pink Sheet Daily

Executive Summary

One of FDA's three draft guidances on DTC advertising requests that consumer-friendly language be used. Commissioner McClellan calls proposed brief summary alternatives a "win-win" and suggests manufacturers will be able to reduce their advertising costs as a result.

You may also be interested in...



DTC Print Ads: Package Insert Info Is Out, Drug Facts Box Is In

FDA’s revised draft guidance for disclosing risk information in direct-to-consumer print ads advises against the use of package insert information in the brief summary; suggests Drugs Facts box or Q&A as alternative formats.

GSK/Roche's Boniva Print Ad Uses Question-And-Answer Brief Summary

Print campaign for the osteoporosis agent uses a reprint of the patient information sheet, which is in a Q&A format, instead of traditional brief summary format. The campaign highlights Boniva's unique once-monthly dosing regimen.

GSK/Roche's Boniva Print Ad Uses Question-And-Answer Brief Summary

Print campaign for the osteoporosis agent uses a reprint of the patient information sheet, which is in a Q&A format, instead of traditional brief summary format. The campaign highlights Boniva's unique once-monthly dosing regimen.

Related Content

Topics

UsernamePublicRestriction

Register

PS058744

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel